Lv11
10 积分 2024-12-06 加入
Preclinical disposition and pharmacokinetics-pharmacodynamic modeling of biomarker response and tumour growth inhibition in xenograft mouse models of G-573, a MEK inhibitor
4小时前
待确认
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
1个月前
已完结
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
1个月前
已完结
Synergistic antitumor activity of the SN‐38‐incorporating polymeric micelles NK012 with S‐1 in a mouse model of non‐small cell lung cancer
2个月前
已完结
A Mouse Model for Eosinophilic Esophagitis (EoE)
2个月前
已完结
The keys to the kingdom. How can healthcare organizations grant access to clinical data and applications, while protecting a patient's privacy? For one integrated health system, automated provisioning held the key
2个月前
已关闭
Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions
2个月前
已关闭
mTOR inhibition and trastuzumab-emtansine (T-DM1) in HER2-positive 1 breast cancer
2个月前
已完结
An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
4个月前
已完结
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies
5个月前
已完结
皖公网安备34019202002308
